STREPTOCIDE

Ukraine

The ointment is used for ulcers, burns, fissures, wounds, pyoderma, erysipelas, purulent inflammatory skin processes without significant exudation, as well as for infected wounds in the healing stage.

Brand name STREPTOCIDE

Dosage form ointment

Active substance / Dosage

sulfanilamide · 100 mg/g

Prescription type over-the-counter (OTC)

ATC code

D06BA05

Registration number UA/4611/02/01

Manufacturer JSC "Lubnipharm"

Frequently asked questions

How should Streptocide ointment be applied correctly?

The preparation is applied in a thin layer to the affected area, specifically under a gauze bandage. The number of daily applications and the duration of the course should be determined by a physician depending on the severity of the condition.

What side effects can Streptocide cause?

In case of hypersensitivity, local allergic reactions such as dermatitis or urticaria may occur. In such cases, use of the ointment should be discontinued immediately.

Who should not use this preparation?

Use is contraindicated in cases of hypersensitivity to the ointment components or other sulfonamides, renal failure, and acute porphyria. The preparation is also not recommended for pregnant women, breastfeeding women, and children.

Can the ointment be combined with other medicines?

It is undesirable to take digitoxin, hydrochloric acid, caffeine, mezaton, phenobarbital, and adrenaline hydrochloride. Additionally, novocaine may reduce the efficacy of the ointment if they are applied immediately one after another.

What should be done if you accidentally used too much ointment?

Overdose may increase the side effects of the preparation. In such cases, symptomatic therapy is administered.

Instructions for use

Table of contents

Composition:
Pharmacological properties.
Clinical characteristics.
Special precautions.
Method of administration and dosage.
Adverse reactions.

INSTRUCTIONS FOR MEDICAL USE OF THE MEDICINAL PRODUCT STREPTOCIDE

Composition:

Active ingredient: 1 g of ointment contains 100 mg of sulfanilamide;

Excipients: white soft paraffin, mineral oil.

Pharmaceutical form. Ointment.

Main physicochemical properties: homogeneous thick mass of white or light yellow color.

Pharmacotherapeutic group.

Chemotherapeutic agents for topical use. Sulfonamides. ATC code D06B A05.

Pharmacological properties.

Pharmacodynamics.

The drug exerts antimicrobial effects against streptococci and other microorganisms. Streptocide disrupts the microbial cell's assimilation of its growth factors—folic acid, dihydrofolic acid, and other compounds containing para-aminobenzoic acid (PABA). Due to the similarity in chemical structure between PABA and sulfanilamide, the latter acts as a competitive antagonist of the acid, entering microbial metabolism and disrupting it.

Clinical characteristics.

Indications.

Ulcers, burns, fissures, wounds, pyoderma, skin ulcers, purulent-inflammatory skin conditions not accompanied by pronounced exudation, infected wounds in the regeneration phase.

Contraindications.

Hypersensitivity to the components of the drug or to any other sulfonamide agents.

Renal insufficiency, acute porphyria.

Special precautions.

If an allergic reaction occurs at the site of ointment application, the use of the drug should be discontinued.

Premature discontinuation of treatment may lead to the development of sulfonamide-resistant microorganisms.

Interaction with other medicinal products and other types of interactions.

During the use of Streptocide ointment, it is undesirable to take digoxin, hydrochloric acid, caffeine, mesaton, phenobarbital, epinephrine hydrochloride. Procaine, which contains a para-aminobenzoic acid residue, reduces the effectiveness of the drug when these medicinal products are used consecutively.

Special precautions.

Use during pregnancy or breastfeeding.

The drug is contraindicated.

Ability to affect reaction rate when driving or operating machinery.

Does not affect.

Method of administration and dosage.

Streptocide, ointment, is applied in a thin layer to the affected area, including under a gauze dressing. Frequency and duration of use depend on the severity of the disease, the therapeutic effect achieved, and are determined by the physician.

Children.

The safety and efficacy of Streptocide in children have not been established; therefore, the use of the drug is not recommended in this age group.

Overdose.

In case of overdose, an increase in the drug's adverse effects is possible.

Treatment: symptomatic therapy.

Adverse reactions.

In case of hypersensitivity to sulfonamide agents, local allergic reactions may occur, including dermatitis and urticaria; if such reactions develop, the drug must be discontinued immediately.

Shelf life. 5 years.

Storage conditions.

Store in the original packaging at a temperature between 8 °C and 15 °C.

Keep out of reach of children.

Packaging.

25 g in tubes No. 1 or jars.

Prescription status. Over-the-counter.

Manufacturer.

JSC "Lubnypharm".

Manufacturer's address and location of business activity.

16, Barvinkova Street, Lubny, Poltava region, 37500, Ukraine.

INSTRUCTION

for medical use of medicinal product

STREPTOCID

Composition:

Active ingredient: 1 g of ointment contains sulfanilamide 100 mg;

Excipients: soft white paraffin, mineral oil.

Pharmaceutical form. Ointment.

Main physicochemical properties: homogeneous thick mass of white or light yellow color.

Pharmacotherapeutic group.

Chemotherapeutic agents for topical use. Sulfonamides.

ATC code D06B A05.

Pharmacological properties.

Pharmacodynamics.

The drug exerts antimicrobial action against streptococci and other microorganisms. Streptocid disrupts the assimilation process of microbial cell growth factors – folic acid, dihydrofolic acid, and other compounds containing para-aminobenzoic acid (PABA). Due to the similarity in chemical structure between PABA and sulfanilamide, the latter acts as a competitive antagonist of the acid, incorporates into microbial metabolism, and disrupts it.

Clinical characteristics.

Indications.

Ulcers, burns, fissures, wounds, pyoderma, erysipelas, purulent-inflammatory skin conditions not accompanied by significant exudation, infected wounds in the regeneration phase.

Contraindications.

Hypersensitivity to the components of the drug or to any other sulfonamide agents.

Renal failure, acute porphyria.

Special precautions.

If an allergic reaction occurs at the site of ointment application, the use of the drug should be discontinued.

Premature discontinuation of treatment with the drug may lead to the development of sulfonamide-resistant microorganisms.

Interaction with other medicinal products and other types of interactions.

During the use of Streptocid ointment, it is undesirable to take drugs such as digitoxin, hydrochloric acid, caffeine, mesaton, phenobarbital, and hydrochloride of adrenaline. Procaine, which contains para-aminobenzoic acid residue, reduces the efficacy of the drug when these medicinal products are used consecutively.

Instructions for use.

Use during pregnancy or breastfeeding.

The drug is contraindicated.

Ability to influence reaction rate when operating a vehicle or other machinery.

Does not affect.

Method and dosage of administration.

Streptocid ointment is applied in a thin layer to the affected area, including under a gauze dressing. Frequency and duration of use depend on the severity of the disease and the therapeutic effect achieved, and are determined by a physician.

Children.

Safety and efficacy of Streptocid in children have not been established; therefore, the use of the drug in this age group is not recommended.